Newsroom

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic, “off the shelf”, cell therapies for serious medical conditions, today announced that the Company has acquired NeuroAirmid Therapeutics, Inc. (“NeuroAirmid”) along with certain worldwide rights related to a pluripotent stem cell derived, clinical-stage neural cell therapy program, hNSC-01, which Lineage calls HUNT1, for the treatment of H...

LANSDOWNE, Va.--(BUSINESS WIRE)--Fortreum, the trust partner to the world's most secure enterprises, today announced general availability of Fortreum VDR/VER, powered by Kovr. The offering helps every FedRAMP-certified cloud service provider (CSP) detect, evaluate, and report vulnerabilities under FedRAMP's new Vulnerability Detection and Response (VDR) and Vulnerability Evaluation and Reporting (VER) rulesets, which become a condition of certification on Dec. 7, with a grace period that closes...

TORONTO--(BUSINESS WIRE)--Patsnap, l'entreprise spécialisée dans l'intelligence stratégique pour l'innovation native de l'IA au service des équipes de propriété intellectuelle et de R&D, a publié aujourd'hui un rapport de référence : « State of Pharma Intelligence 2026: The Confidence to Act » (État de l'intelligence pharmaceutique 2026 : la confiance nécessaire pour agir) portant sur l'utilisation et la confiance accordée par les équipes pharmaceutiques à l'IA dans leurs décisions de R&...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

TORONTO--(BUSINESS WIRE)--Patsnap, das KI-native Innovationsintelligenz-Unternehmen für IP- und F&E-Teams, hat heute den Bericht „State of Pharma Intelligence 2026: The Confidence to Act“ (Stand der Pharma-Informationen 2026: Die Zuversicht, zu handeln) veröffentlicht, einen Benchmark-Bericht darüber, wie Pharma-Teams KI bei Entscheidungen in den Bereichen F&E, Wettbewerbsanalyse und Geschäftsentwicklung einsetzen und wie groß ihr Vertrauen in diese Technologie ist. Der Bericht stützt s...

PITTSBURGH--(BUSINESS WIRE)--Smith Micro Software, Inc. (Nasdaq: SMSI) (“Smith Micro” or the “Company”) today reported financial results for its third quarter ended September 30, 2026. “Our third quarter marked our third consecutive quarter of sequential revenue growth as we continued to build on the momentum established in the first half of the year,” said William W. Smith Jr., president, chief executive officer, and chairman of the board of Smith Micro. “Revenue increased 16% sequentially and...

TORONTO & SEATTLE--(BUSINESS WIRE)--POSaBIT Systems Corporation (CSE: PBIT, OTC: POSAF) (the “Company” or “POSaBIT”), a leading provider of Point of Sale and payment solutions for the cannabis industry, today announced its financial results for the third quarter ended September 30, 2026. “Our Point of Sale business continues to deliver strong growth, up 39% year over year in Q3. That growth expands our recurring revenue from monthly and annual SaaS fees, which reduces risk to the business and m...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2026 Results...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2026 fiscal year ended September 30, 2026. The Company is hosting a conference call today, November 12, 2026, at 4:30 p.m. ET to discuss the results. “Arrowhead has fundamentally changed over the past 12 months. Where there was once a company that relied solely on great scientific promise, there is now a company that is beginning to translate promise into real patient outc...

DALLAS & FRANKFURT, Germany--(BUSINESS WIRE)--Celanese Completes Sale of Nutrinova Joint Venture Shares to Mitsui & Co., Ltd....